Uso do Ciprofloxacino em diferentes doses incorporado em dispositivo de quitosana na prevenção da infecção em modelo de fraturas expostas em ratos

Detalhes bibliográficos
Ano de defesa: 2017
Autor(a) principal: Silvia Iovine Kobata
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Minas Gerais
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: https://hdl.handle.net/1843/BUBD-AW6GSD
Resumo: Open fractures are mainly caused by high-energy accidents. Osteomyelitis are the most common complication from open fractures and its treatment involves surgical treatment and high doses of systemic antibiotics. Despite all medical and pharmacological advances, infection rates after open fractures has not changed in the past 20 years, promoting high social and economic costs. A bio absorbable carrier for ciprofloxacin could prevent the need for additional surgical procedure when impregnated at osteo-fixation device; however, the exact concentration of ciprofloxacin that would prevent infection at the open fracture site remains controversial. Objective. Evaluate efficiency of local delivery treatment using different concentrations of ciprofloxacin incorporated at the fixation device using quitosana as carrier, a bio absorbable polymer, in order to prevent infection after open fracture contaminated with S. aureus in rats. Methods. 52 Wistar rats underwent to an established S aureus contaminated fracture model. All animals assigned to one of six groups after one hour of bacterial contamination. Group A underwent to fracture fixation using K-wire but no antibiotic treatment (control group). Group B after fracture fixation with K-wire had systemic ciprofloxacin treatment. Group C underwent to fracture fixation using K-wire impregnated with quitosana only. Group D had fracture fixation using K-wire with quitosana and 10% ciprofloxacin impregnated. Group E underwent to fracture fixation using K-wire with quitosana and 25% ciprofloxacin impregnated, and group F had fracture fixation using K-wire with quitosana and 50% ciprofloxacin impregnated. After 4 weeks, all animals underwent to an established 99mTc-ceftizoxima scintigraphy evaluation, callus formation measurement and histological analysis. ANOVA, t-Student and Kruskal Wallis were used for quantitative variables statistical analysis, whereas qui square and exact Fisher were used for qualitative variables. Results. Treatment using 25% and 50% of ciprofloxacin incorporated at the fracture fixation device were effective in preventing bone infection compared to control group (p<0,05). Quitosana were not effective in preventing bone infection when used alone compared to control group (p>0,05). Histological findings demonstrated bone-healing delay with 50% of ciprofloxacin treatment. However, no difference in callus formation measurement were observed between groups (p>0,05). Conclusion. Local delivery treatment for contaminated open fracture with Staphylococcus aureus using a bio absorbable polymer with ciprofloxacin impregnated is effective when ciprofloxacin concentration is above 25% in rats.
id UFMG_8d3ef43e2b5c2b1e0764ee7e2bbed1b4
oai_identifier_str oai:repositorio.ufmg.br:1843/BUBD-AW6GSD
network_acronym_str UFMG
network_name_str Repositório Institucional da UFMG
repository_id_str
spelling Uso do Ciprofloxacino em diferentes doses incorporado em dispositivo de quitosana na prevenção da infecção em modelo de fraturas expostas em ratosOsteomieliteFraturas Ósseas/complicaçõesCiprofloxacino/uso terapêuticoMedicinaFraturas ósseas/complicaçõesOsteomielite/tratamento99mTc-CFTFratura expostaOsteomielite/cintilografiaOpen fractures are mainly caused by high-energy accidents. Osteomyelitis are the most common complication from open fractures and its treatment involves surgical treatment and high doses of systemic antibiotics. Despite all medical and pharmacological advances, infection rates after open fractures has not changed in the past 20 years, promoting high social and economic costs. A bio absorbable carrier for ciprofloxacin could prevent the need for additional surgical procedure when impregnated at osteo-fixation device; however, the exact concentration of ciprofloxacin that would prevent infection at the open fracture site remains controversial. Objective. Evaluate efficiency of local delivery treatment using different concentrations of ciprofloxacin incorporated at the fixation device using quitosana as carrier, a bio absorbable polymer, in order to prevent infection after open fracture contaminated with S. aureus in rats. Methods. 52 Wistar rats underwent to an established S aureus contaminated fracture model. All animals assigned to one of six groups after one hour of bacterial contamination. Group A underwent to fracture fixation using K-wire but no antibiotic treatment (control group). Group B after fracture fixation with K-wire had systemic ciprofloxacin treatment. Group C underwent to fracture fixation using K-wire impregnated with quitosana only. Group D had fracture fixation using K-wire with quitosana and 10% ciprofloxacin impregnated. Group E underwent to fracture fixation using K-wire with quitosana and 25% ciprofloxacin impregnated, and group F had fracture fixation using K-wire with quitosana and 50% ciprofloxacin impregnated. After 4 weeks, all animals underwent to an established 99mTc-ceftizoxima scintigraphy evaluation, callus formation measurement and histological analysis. ANOVA, t-Student and Kruskal Wallis were used for quantitative variables statistical analysis, whereas qui square and exact Fisher were used for qualitative variables. Results. Treatment using 25% and 50% of ciprofloxacin incorporated at the fracture fixation device were effective in preventing bone infection compared to control group (p<0,05). Quitosana were not effective in preventing bone infection when used alone compared to control group (p>0,05). Histological findings demonstrated bone-healing delay with 50% of ciprofloxacin treatment. However, no difference in callus formation measurement were observed between groups (p>0,05). Conclusion. Local delivery treatment for contaminated open fracture with Staphylococcus aureus using a bio absorbable polymer with ciprofloxacin impregnated is effective when ciprofloxacin concentration is above 25% in rats.Universidade Federal de Minas Gerais2019-08-12T18:12:17Z2025-09-09T01:15:54Z2019-08-12T18:12:17Z2017-09-18info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttps://hdl.handle.net/1843/BUBD-AW6GSDSilvia Iovine Kobatainfo:eu-repo/semantics/openAccessporreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMG2025-09-09T01:15:54Zoai:repositorio.ufmg.br:1843/BUBD-AW6GSDRepositório InstitucionalPUBhttps://repositorio.ufmg.br/oairepositorio@ufmg.bropendoar:2025-09-09T01:15:54Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false
dc.title.none.fl_str_mv Uso do Ciprofloxacino em diferentes doses incorporado em dispositivo de quitosana na prevenção da infecção em modelo de fraturas expostas em ratos
title Uso do Ciprofloxacino em diferentes doses incorporado em dispositivo de quitosana na prevenção da infecção em modelo de fraturas expostas em ratos
spellingShingle Uso do Ciprofloxacino em diferentes doses incorporado em dispositivo de quitosana na prevenção da infecção em modelo de fraturas expostas em ratos
Silvia Iovine Kobata
Osteomielite
Fraturas Ósseas/complicações
Ciprofloxacino/uso terapêutico
Medicina
Fraturas ósseas/complicações
Osteomielite/tratamento
99mTc-CFT
Fratura exposta
Osteomielite/cintilografia
title_short Uso do Ciprofloxacino em diferentes doses incorporado em dispositivo de quitosana na prevenção da infecção em modelo de fraturas expostas em ratos
title_full Uso do Ciprofloxacino em diferentes doses incorporado em dispositivo de quitosana na prevenção da infecção em modelo de fraturas expostas em ratos
title_fullStr Uso do Ciprofloxacino em diferentes doses incorporado em dispositivo de quitosana na prevenção da infecção em modelo de fraturas expostas em ratos
title_full_unstemmed Uso do Ciprofloxacino em diferentes doses incorporado em dispositivo de quitosana na prevenção da infecção em modelo de fraturas expostas em ratos
title_sort Uso do Ciprofloxacino em diferentes doses incorporado em dispositivo de quitosana na prevenção da infecção em modelo de fraturas expostas em ratos
author Silvia Iovine Kobata
author_facet Silvia Iovine Kobata
author_role author
dc.contributor.author.fl_str_mv Silvia Iovine Kobata
dc.subject.por.fl_str_mv Osteomielite
Fraturas Ósseas/complicações
Ciprofloxacino/uso terapêutico
Medicina
Fraturas ósseas/complicações
Osteomielite/tratamento
99mTc-CFT
Fratura exposta
Osteomielite/cintilografia
topic Osteomielite
Fraturas Ósseas/complicações
Ciprofloxacino/uso terapêutico
Medicina
Fraturas ósseas/complicações
Osteomielite/tratamento
99mTc-CFT
Fratura exposta
Osteomielite/cintilografia
description Open fractures are mainly caused by high-energy accidents. Osteomyelitis are the most common complication from open fractures and its treatment involves surgical treatment and high doses of systemic antibiotics. Despite all medical and pharmacological advances, infection rates after open fractures has not changed in the past 20 years, promoting high social and economic costs. A bio absorbable carrier for ciprofloxacin could prevent the need for additional surgical procedure when impregnated at osteo-fixation device; however, the exact concentration of ciprofloxacin that would prevent infection at the open fracture site remains controversial. Objective. Evaluate efficiency of local delivery treatment using different concentrations of ciprofloxacin incorporated at the fixation device using quitosana as carrier, a bio absorbable polymer, in order to prevent infection after open fracture contaminated with S. aureus in rats. Methods. 52 Wistar rats underwent to an established S aureus contaminated fracture model. All animals assigned to one of six groups after one hour of bacterial contamination. Group A underwent to fracture fixation using K-wire but no antibiotic treatment (control group). Group B after fracture fixation with K-wire had systemic ciprofloxacin treatment. Group C underwent to fracture fixation using K-wire impregnated with quitosana only. Group D had fracture fixation using K-wire with quitosana and 10% ciprofloxacin impregnated. Group E underwent to fracture fixation using K-wire with quitosana and 25% ciprofloxacin impregnated, and group F had fracture fixation using K-wire with quitosana and 50% ciprofloxacin impregnated. After 4 weeks, all animals underwent to an established 99mTc-ceftizoxima scintigraphy evaluation, callus formation measurement and histological analysis. ANOVA, t-Student and Kruskal Wallis were used for quantitative variables statistical analysis, whereas qui square and exact Fisher were used for qualitative variables. Results. Treatment using 25% and 50% of ciprofloxacin incorporated at the fracture fixation device were effective in preventing bone infection compared to control group (p<0,05). Quitosana were not effective in preventing bone infection when used alone compared to control group (p>0,05). Histological findings demonstrated bone-healing delay with 50% of ciprofloxacin treatment. However, no difference in callus formation measurement were observed between groups (p>0,05). Conclusion. Local delivery treatment for contaminated open fracture with Staphylococcus aureus using a bio absorbable polymer with ciprofloxacin impregnated is effective when ciprofloxacin concentration is above 25% in rats.
publishDate 2017
dc.date.none.fl_str_mv 2017-09-18
2019-08-12T18:12:17Z
2019-08-12T18:12:17Z
2025-09-09T01:15:54Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/1843/BUBD-AW6GSD
url https://hdl.handle.net/1843/BUBD-AW6GSD
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Minas Gerais
publisher.none.fl_str_mv Universidade Federal de Minas Gerais
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMG
instname:Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
instname_str Universidade Federal de Minas Gerais (UFMG)
instacron_str UFMG
institution UFMG
reponame_str Repositório Institucional da UFMG
collection Repositório Institucional da UFMG
repository.name.fl_str_mv Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)
repository.mail.fl_str_mv repositorio@ufmg.br
_version_ 1879513246608654336